ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Apr 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
June 2026
Nuclear Technology
March 2026
Fusion Science and Technology
May 2026
Latest News
DOE selects first companies for nuclear launch pad
The Department of Energy’s Office of Nuclear Energy and the National Reactor Innovation Center have announced their first selections for the Nuclear Energy Launch Pad: three companies developing microreactors and one developing fuel supply.
The four companies—Deployable Energy, General Matter, NuCube Energy, and Radiant Industries—were selected from the initial pool of Reactor Pilot Program and Fuel Line Pilot Program applicants, the two precursor programs to the launch pad.
J. H. Dave, J. J. Egan, G. P. Couchell, G. H. R. Kegel, A. Mittler, D.J. Pullen, W. A. Schier, E.Sheldon
Nuclear Science and Engineering | Volume 91 | Number 2 | October 1985 | Pages 187-208
Technical Paper | doi.org/10.13182/NSE85-A27441
Articles are hosted by Taylor and Francis Online.
Neutron inelastic scattering from 232Th has been studied for states above 700 keV in excitation using the (n,n'γ) technique at incident energies in the 0.77- to 2.10-MeV range. The gamma-ray measurements employing a high-resolution Ge(Li) spectrometer show 74 transitions from 46 levels above the first excited state. Gamma-ray branching ratios and production cross sections have been determined. Inferred level cross sections are compared to compound-nucleus statistical model calculations, which generally represent the measurements fairly well at lower incident energies but become increasingly discrepant at higher bombarding energies, and to the ENDF/B-V evaluation.